| Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes CC Coombs, A Zehir, SM Devlin, A Kishtagari, A Syed, P Jonsson, ... Cell stem cell 21 (3), 374-382. e4, 2017 | 675 | 2017 |
| Driver mutations in acute myeloid leukemia A Kishtagari, RL Levine, AD Viny Current opinion in hematology 27 (2), 49-57, 2020 | 69 | 2020 |
| Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia H Awada, A Durmaz, C Gurnari, A Kishtagari, M Meggendorfer, CM Kerr, ... Blood, The Journal of the American Society of Hematology 138 (19), 1885-1895, 2021 | 44 | 2021 |
| Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes C Saygin, A Kishtagari, RD Cassaday, N Reizine, I Yurkiewicz, M Liedtke, ... Blood advances 3 (24), 4228-4237, 2019 | 37 | 2019 |
| Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome J Durrani, H Awada, A Kishtagari, V Visconte, C Kerr, V Adema, Y Nagata, ... Leukemia 34 (3), 957-962, 2020 | 35 | 2020 |
| The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders S Pagliuca, C Gurnari, H Awada, A Kishtagari, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 138 (26), 2781-2798, 2021 | 30 | 2021 |
| Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology DA Pollyea, JK Altman, R Assi, D Bixby, AT Fathi, JM Foran, I Gojo, ... Journal of the National Comprehensive Cancer Network 21 (5), 503-513, 2023 | 29 | 2023 |
| Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes BM Getta, A Kishtagari, P Hilden, MS Tallman, M Maloy, P Gonzales, ... Biology of Blood and Marrow Transplantation 23 (7), 1078-1086, 2017 | 22 | 2017 |
| Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia JM Watts, B Dumitriu, P Hilden, A Kishtagari, F Rapaport, C Chen, J Ahn, ... Leukemia research 49, 62-65, 2016 | 19 | 2016 |
| Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignancies H Awada, RZ Mahfouz, A Kishtagari, T Kuzmanovic, J Durrani, CM Kerr, ... British Journal of Haematology 188 (6), 924-929, 2020 | 16 | 2020 |
| The role of somatic mutations in acute myeloid leukemia pathogenesis A Kishtagari, RL Levine Cold Spring Harbor Perspectives in Medicine 11 (4), a034975, 2021 | 14 | 2021 |
| Biological and clinical implications of telomere dysfunction in myeloid malignancies A Kishtagari, J Watts Therapeutic advances in hematology 8 (11), 317-326, 2017 | 14 | 2017 |
| Melanoma and non‐melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30‐year experience at Memorial Sloan … JM Watts, A Kishtagari, M Hsu, ME Lacouture, MA Postow, JH Park, ... British journal of haematology 171 (1), 84-90, 2015 | 14 | 2015 |
| Novel invariant features of Good syndrome C Gurnari, J Durrani, S Pagliuca, A Kishtagari, H Awada, CM Kerr, ... Leukemia 35 (6), 1792-1796, 2021 | 13 | 2021 |
| Skeel's Handbook of cancer therapy SN Khleif, O Rixe, R Skeel Lippincott Williams & Wilkins, 2016 | 13 | 2016 |
| Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation S Pagliuca, C Gurnari, S Hong, R Zhao, S Kongkiatkamon, L Terkawi, ... JCI insight 6 (13), 2021 | 12 | 2021 |
| Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation H Awada, RZ Mahfouz, J Durrani, A Kishtagari, D Jagadeesh, AE Lichtin, ... British journal of haematology 189 (2), 318-322, 2020 | 11 | 2020 |
| A first-in-class inhibitor of ISWI-mediated (ATP-dependent) transcription repression releases terminal-differentiation in AML cells while sparing Normal hematopoiesis A Kishtagari, KP Ng, C Jarman, AD Tiwari, JG Phillips, C Schuerger, ... Blood 132, 216, 2018 | 10 | 2018 |
| Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment K von Beck, T von Beck, PB Ferrell Jr, AG Bick, A Kishtagari Blood Cancer Journal 13 (1), 5, 2023 | 8 | 2023 |
| Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia JM Watts, B Dumitriu, P Hilden, C Chen, F Rapaport, A Kishtagari, J Ahn, ... Blood 124 (21), 2280, 2014 | 7 | 2014 |
